A startup’s swallowable robotic pill, designed to enhance telemedicine, is entering clinical trials.
Endiatx has developed PillBot, a mini robotic camera that can be remotely controlled, potentially eliminating the need for more invasive medical procedures.
PillBot, a virtual endoscope or a “moving eyeball in the stomach,” utilizes pumpjet thrusters similar to multicopter drones. This allows precise navigation within the gastrointestinal tract.
Endiatx, based in California, claims the pill allows patients worldwide to consult top gastroenterologists from home.
Many stomach cancer cases, including 11,000 annually in the U.S. and 800,000 globally, are diagnosed too late for effective treatment, often due to the unavailability of traditional upper endoscopy due to overbooked staff and facilities.
Since 2019, Endiatx has focused on utilizing miniature robots for diagnostic and therapeutic purposes in the human body.
PillBot, an ingestible capsule, is equipped with cameras, sensors, and wireless communication technology, which provides doctors with unprecedented detail and control during examinations.
According to its developers, PillBot will save lives, reduce the strain on healthcare facilities and expand access to stomach cancer screening through telemedicine, particularly for those with limited hospital access.
This innovation could significantly transform telemedicine, offering remote diagnostics and enabling gastroenterologists to treat more patients efficiently.
PillBot, roughly the size of a multivitamin, allows real-time internal viewing during telemedicine sessions, potentially replacing traditional endoscopy. Patients can swallow PillBot while awake, with minimal preparation of fasting and hydration.
The current prototype, measuring 13mm by 30mm, streams high-resolution video at 2.3 megapixels per second, and plans are underway to enhance this quality further.
Controlled via a smartphone app, PillBot exits the body naturally within six to twenty-four hours. The development team also integrates AI to assist in preliminary diagnoses, setting the stage for future treatment plans.
